Product Name:Cyclopropanamine, 2-(4-fluorophenyl)-, (1R,2S)- (9CI)

IUPAC Name:(1R,2S)-2-(4-fluorophenyl)cyclopropan-1-amine

CAS:220349-80-4
Molecular Formula:C9H10FN
Purity:95%+
Catalog Number:CM433351
Molecular Weight:151.18

Packing Unit Available Stock Price($) Quantity
CM433351-1g in stock ȺȺȺȬ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:220349-80-4
Molecular Formula:C9H10FN
Melting Point:-
Smiles Code:N[C@@H]1C[C@H]1C1=CC=C(F)C=C1
Density:
Catalog Number:CM433351
Molecular Weight:151.18
Boiling Point:
MDL No:MFCD17010161
Storage:

Column Infos

Bomedemstat
Merck recently announces the initiation of the pivotal Phase 3 randomized MK-3543-006 clinical trial of Bomedemstat for Essential Thrombocythemia (ET). Lysine-specific demethylase 1 (LSD1) is critical for the regulation of hematopoietic stem and progenitor cells. Bomedemstat is an investigational small molecule irreversible inhibitor of LSD1 by suppressing progenitor cells during blood cell maturation. It is generally well tolerated in ET patients and demonstrates significant clinical activity as a monotherapy.
Bomedemstat has been granted Orphan Drug and Fast Track Designation for the treatment of ET and myelofibrosis (MF) by the U.S. FDA.